Safety, tolerability, and pharmacokinetic of HY0721 in Chinese healthy subjects: A first-in-human randomized, double-blind, placebo-controlled dose escalation phase I study

Update your browser to view ScienceDirect.

Request details:

Request ID: 89769c9d48b85c1d-SJC
IP: 116.62.10.13
UTC time: 2024-06-21T20:05:09+00:00
Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4